Darifenacin N-Oxide (Mixture of Diasteromers)
Stock Status: In Stock
Login to view price
Live
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Research & Analytical Use Only
Not for personal use. Handle as per laboratory safety practices.
Not for personal use. Handle as per laboratory safety practices.
Storage: Store at refrigerator (2-8°C) for long term storage
Hazard: Refer MSDS for accurate information.
Darifenacin N-Oxide (Mixture of Diasteromers) Product Information
Darifenacin N-Oxide (Mixture of Diasteromers) is listed under Metabolite and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Darifenacin. The product is supplied by Clearsynth under CAT No. CS-O-14951.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Darifenacin N-Oxide (Mixture of Diasteromers)
CAS No.
1391080-40-2
CAT No.
CS-O-14951
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C₂₈H₃₀N₂O₃
Molecular Weight
442.55
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
(3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Darifenacin N-Oxide (Mixture of Diasteromers) is chemically (3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidine 1-oxide. Darifenacin N-Oxide (Mixture of Diasteromers) is supplied with detailed characterization data compliant with regulatory guideline. Darifenacin N-Oxide (Mixture of Diasteromers) can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Darifenacin.
Overview
Impurity in commercial preparation of Darifenacin.
Synonyms
Not available
Application Notes
Impurity in commercial preparation of Darifenacin.
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.
Related Darifenacin Products
Darifenacin Hydrochloride
Darifenacin R-Isomer Hydrochloride
Darifenacin nitroso impurity
Darifenacin 4-Hydroxy Impurity
Darifenacin 4-Hydroxy Impurity
Darifenacin-d4 Hydrochloride
Darifenacin Nitrile Impurity (HCl)
Darifenacin Impurity 10 (Tartarate salt)
Darifenacin-d4 Hydrobromide
